Arkolith/Insider Trading/BBLG/Form 4

Gagnon Robert E.

DirectorBone Biologics Corp (BBLG) · full profile →Form 4 · filed Jan 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 8, 2024Grant(A)8—$08K
Jan 8, 2024Grant(A)9—$09

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-001971) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML